XBIT - XBiotech Inc.
IEX Last Trade
7.585
0 0%
Share volume: 0
Last Updated: Tue 24 Dec 2024 05:57:49 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.45%
PREVIOUS CLOSE
CHG
CHG%
$7.58
-3.22
0.74%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-10 | 2022-08-10 | 2022-11-09 | 2023-03-15 | 2023-05-10 | 2023-08-11 | 2023-11-09 | |
| Assets | ||||||||
| Total Assets | 270.803 M | 266.462 M | 250.834 M | 246.103 M | 242.121 M | 235.136 M | 229.599 M | |
| Current Assets | 242.980 M | 238.764 M | 223.427 M | 219.843 M | 216.284 M | 209.512 M | 204.402 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 632.000 K | 545.000 K | 60.153 M | 60.773 M | 60.881 M | 62.327 M | 879.000 K | |
| Short Term Investments | 632.000 K | 545.000 K | 60.153 M | 60.773 M | 60.881 M | 62.327 M | 879.000 K | |
| Total Receivables | 10.527 M | 12.426 M | 2.706 M | 1.764 M | 2.919 M | 3.794 M | 1.332 M | |
| Current Cash | 231.821 M | 225.793 M | 160.568 M | 157.306 M | 152.484 M | 143.391 M | 202.191 M | |
| Total Non-current Assets | 27.823 M | 27.698 M | 27.407 M | 26.260 M | 25.837 M | 25.624 M | 25.197 M | |
| Property Plant Equipment | 27.823 M | 27.276 M | 26.635 M | 26.260 M | 25.837 M | 25.624 M | 25.197 M | |
| Other Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 270.803 M | 266.462 M | 250.834 M | 246.103 M | 242.121 M | 235.136 M | 229.599 M | |
| Total liabilities | 5.243 M | 10.667 M | 6.025 M | 5.701 M | 5.216 M | 6.073 M | 6.940 M | |
| Total current liabilities | 2.891 M | 8.235 M | 3.578 M | 4.066 M | 3.618 M | 4.450 M | 5.294 M | |
| Accounts Payable | 1.323 M | 2.647 M | 1.590 M | 2.463 M | 1.412 M | 1.816 M | 1.627 M | |
| Other liabilities | 1.479 M | 1.559 M | 1.575 M | 1.576 M | 1.598 M | 1.623 M | 1.646 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.479 M | 1.559 M | 1.575 M | 1.576 M | 1.598 M | 1.623 M | 1.646 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 265.560 M | 255.795 M | 244.809 M | 240.402 M | 236.905 M | 229.063 M | 222.659 M | |
| Common stock | 30.043 M | 30.439 M | 30.439 M | 30.835 M | 30.439 M | 30.439 M | 30.437 M | |
| Retained earnings | -244.000 K | -11.888 M | -24.546 M | -27.749 M | -31.565 M | -40.307 M | -47.671 M |